Oncostatin M: friend or foe in PCOS pathogenesis?
Nikanfar S, Oghbaei F, Nejabati HR, Zarezadeh R, Latifi Z, Laleh SH, Khodavirdilou L, Khodavirdilou R, Amorim CA, Fattahi A.
Nikanfar S, et al.
J Endocrinol. 2024 Nov 18;263(3):e240140. doi: 10.1530/JOE-24-0140. Print 2024 Dec 1.
J Endocrinol. 2024.
PMID: 39377389
Review.
Although adipokines have been recognized in the development of PCOS, the role of oncostatin M (OSM), a multifaceted adipokine, remains unclear. Current evidence suggests that this cytokine is associated with key aspects of the syndrome, including obesity, insulin resistanc …
Although adipokines have been recognized in the development of PCOS, the role of oncostatin M (OSM), a multifaceted adipokine, remain …